The researcherslimited their analysis to randomized controlled trials, which are the goldstandardofclinicalresearch, toensure thatonly the highestqualitydata were used.
World Bank President Robert Zoellick jumped into the fray on Monday, suggesting in a Financial Times commentary a limited return to the goldstandard to provide stability to the markets.